Skip to content

Effectiveness and Costs of Enhanced Cocaine Treatments

Status
Completed
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00167258
Enrollment
Unknown
Registered
2005-09-14
Start date
Unknown
Completion date
2007-02-28
Last updated
2009-12-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cocaine Dependence

Brief summary

The study will evaluate the effectiveness, economic benefits, and costs of voucher reinforcement for cocaine and alcohol abstinence, additional counseling services, and their combination in a sample of cocaine dependent patients receiving outpatient treatment as usual in a community clinic.

Interventions

BEHAVIORALExtra Counseling Services
BEHAVIORALVoucher Reinforcement + Extra Counseling Services

Sponsors

University of Pennsylvania
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
FACTORIAL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years

Inclusion criteria

* Enrollment in an intensive outpatient program (IOP) for no more than 1 month * Current DSM-IV diagnosis of cocaine dependence (month prior to IOP treatment) * 18-65 years of age * Ability to provide names of informants to help locate subject for follow-up

Exclusion criteria

* IV heroin use in last year * Acute medical/psychiatric diagnosis that precludes outpatient treatment * Inpatient treatment for 6 weeks or more prior to IOP treatment * Incarceration for 6 months or more prior to IOP treatment

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026